281. Klippel-Trenaunay-Weber syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 52
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
KP-001
Kaken Pharmaceutical
2026 Phase 3 NCT07285005 -
RLY-2608
Relay Therapeutics, Inc.
2025 Phase 2 NCT06789913 Australia;Belgium;Germany;Italy;Spain;United Kingdom;United States
Search FOR polymorphisms OF RASA1 gene
University Hospital, Tours
2010 - NCT01364857 France
Sirolimus
Gifu University
2017 - JPRN-UMIN000030522 Japan
Kaken Pharmaceutical
2026 Phase 3 NCT07285005 -
RLY-2608
Relay Therapeutics, Inc.
2025 Phase 2 NCT06789913 Australia;Belgium;Germany;Italy;Spain;United Kingdom;United States
Search FOR polymorphisms OF RASA1 gene
University Hospital, Tours
2010 - NCT01364857 France
Sirolimus
Gifu University
2017 - JPRN-UMIN000030522 Japan
